Journal of Pharmaceutical Investigation

The Korean Society of Pharmaceutical Sciences and Technology (한국약제학회)
권호 표지
DOI QR코드

DOI QR Code

Reduction of Oncogene Expression in Cancer Cells Using siRNA Delivery Systems

  • Published : 2005.10.20
Download PDF
⟨ Previous Next ⟩

Abstract

Recently, siRNA has been emerging as new therapeutic agents for various diseases such as cancers and infectious diseases. However, the evaluation for delivery systems for siRNA has not been fully done. In this study, we designed and delivered siRNA of oncogenic E6 and E7 proteins to several cell lines and tested the delivery efficiencies of various cationic nonviral delivery vectors. Of cationic delivery systems tested in this study, lipid-based Lipofectamine revealed higher delivery efficiency of siRNA to cervical cancer cell line, SiHa, compared to other delivery systems. Notably, the polyethylenimine, which showed the comparable delivery efficiencies in plasmid DNA, did not show significant delivery of siRNA in cervical cancer cells. These results indicate that the mechanisms involved in siRNA delivery might be different from those in plasmid DNA delivery, and that cationic lipid-based delivery vehicles deliver siRNA with higher efficiency to intracellular target sites.

Keywords

References

  1. R.C. Ryther, A.S. Flynt, J.A. Phillips, 3rd and J.G. Patton, siRNA therapeutics: big potential from small RNAs, Gene Ther., 12, 5-11 (2005) https://doi.org/10.1038/sj.gt.3302356
  2. D.V. Morrissey, J.A. Lockridge, L. Shaw, K. Blanchard, K. Jensen, W. Breen, K. Hartsough, L. Machemer, S. Radka, V. Jadhav, N. Vaish, S. Zinnen, C. Vargeese, K. Bowman, C.S. Shaffer, L.B. Jeffs, A. Judge, J. MacLachlan and B. Polisky, Potent and persistent in vivo anti-HEV activity of chemically modified siRNAs, Nature Biotech., 23, 1002-7 (2005) https://doi.org/10.1038/nbt1122
  3. U. Fuchs, C. Damm-Welk and A Borkhardt, Silencing of disease-related genes by small interfering RNAs, Curr. Mol. Med, 4, 507-17 (2004) https://doi.org/10.2174/1566524043360492
  4. S.N. Templeton, Liposomal delivery of nucleic acids in vivo, DNA Cell. Biol., 21, 859-67 (2002)
  5. J.W. Wiseman, C.A. Goddard, D. McLelland and W.H. Colledge, A comparison of linear and branched polyethylenimine (PEl) with DCChol/DOPE liposomes for gene delivery to epithelial cells in vitro and in vivo, Gene Ther., 10, 1654-62 (2003) https://doi.org/10.1038/sj.gt.3302050
  6. J.-Y. Shin, D.C. Suh, J. M. Kim, H.-G. Choi, J. A. Kim, J. J. Ko, Y.B. Lee, J.-S. Kim and Y.-K. Oh, Low molecular weight polyethylenimine for efficient transfection of human hematopoietic and umbilical cord blood-derived CD34+ cells, Biochim. Biophys. Acta, in press (2005)
  7. T.M. Fountaine, M.J. Wood and R. Wade-Martins, Delivering RNA interference to the mammalian brain, Curr. Gene Ther., 5, 399-410 (2005) https://doi.org/10.2174/1566523054546206
  8. E. Schwarz, U.K. Freese, L. Gissmann, W. Mayer, B. Roggenbuck, A. Stremlau and H.Z. Hausen, Structure and transcription of human papillomavirus sequences in cervical carcinoma cells, Nature, 314, 111-14 (1985) https://doi.org/10.1038/314111a0
  9. B. Yuan, R. Latek, M. Rossbach, T. Tuschl and F. Lewitter, siRNA Selection Server: an automated siRNA oligonucleotide prediction server, Nucleic Acids Res., 32, 130-34 (2004)
  10. B. Urban-Klein, S. Werth, S. Abuharbeid, F. Czubayko and A. Aigner RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo, Gene Ther., 132, 461-66 (2005)
  11. U. Lungwitz, M. Breunig, T. Blunk and A. Gopferich, Polyethylenimine-based non-viral gene delivery systems, Eur. J. Pharm. Biopharm., 60, 247-66 (2005) https://doi.org/10.1016/j.ejpb.2004.11.011
  12. M. Neu, D, Fischer and T. Kissel, Recent advances in rational gene transfer vector design based on poly(ethylene imine) and its derivatives, J. Gene Med., 7, 992-1009 (2005) https://doi.org/10.1002/jgm.773
  13. D.R. Sorensen, M. Leirdal and M. Sioud, Gene silencing by systemic delivery synthetic siRN As in adult mice, J. Mol. BioI. 32, 7, 761-66 (2003)